Blackrock Health Sciences Hedge Fund LLC is a hedge fund based in New York, New York. According to its most recent Form D, filed Mar 18, 2022, the fund has sold $196,060,000 of interests to 42 investors since its first sale in Jun 2006. The minimum investment it accepts from an outside investor is $1,000,000. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Ian Pilgrim; W. Woods; Noelle L'Heuruex.
Performance
No returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $196,060,000Cumulative sales reported on Form D
- Investors
- 42
- First sale
- Jun 1, 2006
- Minimum investment
- $1,000,000
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Ian Pilgrim; W. Woods; Noelle L'Heuruex
- Latest Form D
- Mar 18, 2022
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Mar 18, 2022 | Form D/A (amendment) | $196,060,000 | 42 | SEC.gov ↗ |
| Mar 18, 2021 | Form D/A (amendment) | $196,060,000 | 42 | SEC.gov ↗ |
| Mar 18, 2020 | Form D/A (amendment) | $196,060,000 | 42 | SEC.gov ↗ |
| Mar 18, 2019 | Form D/A (amendment) | $196,060,000 | 42 | SEC.gov ↗ |
| Mar 16, 2018 | Form D/A (amendment) | $196,060,000 | 42 | SEC.gov ↗ |
| Mar 16, 2017 | Form D/A (amendment) | $196,060,000 | 42 | SEC.gov ↗ |
| Mar 16, 2016 | Form D/A (amendment) | $196,060,000 | 42 | SEC.gov ↗ |
| Mar 17, 2015 | Form D/A (amendment) | $196,060,000 | 42 | SEC.gov ↗ |
| Mar 17, 2014 | Form D/A (amendment) | $196,060,000 | 42 | SEC.gov ↗ |
| Mar 16, 2012 | Form D/A (amendment) | $195,473,000 | 41 | SEC.gov ↗ |
10 Form D filings in the SEC's electronic records (2008 onward), the earliest on Mar 16, 2012. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Questions about Blackrock Health Sciences Hedge Fund LLC
What is the minimum investment for Blackrock Health Sciences Hedge Fund LLC?
According to its latest Form D, filed Mar 18, 2022, the minimum investment Blackrock Health Sciences Hedge Fund LLC accepts from an outside investor is $1,000,000.
Who can invest in Blackrock Health Sciences Hedge Fund LLC?
Blackrock Health Sciences Hedge Fund LLC is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Blackrock Health Sciences Hedge Fund LLC raised?
Blackrock Health Sciences Hedge Fund LLC reports $196,060,000 sold from 42 investors on its Form D filed Mar 18, 2022. This is cumulative sales since the offering began, not current assets or performance.
Where is Blackrock Health Sciences Hedge Fund LLC based?
Blackrock Health Sciences Hedge Fund LLC is based in New York, New York.
When did Blackrock Health Sciences Hedge Fund LLC launch?
Blackrock Health Sciences Hedge Fund LLC reports its first sale in Jun 2006.
Size compared with every hedge fund
Raised more than 65% of the 2,528 hedge funds based in New York, and more than 69% of all 10,160 that report sales.
Other funds with the same team
- Fixed Income GlobalAlpha Offshore Fund Ltd.$6.9B
- Two Sigma Active Extension U.S. All Cap Equity Cayman Fund, Ltd.$5.6B
- Two Sigma Absolute Return Enhanced Cayman Fund, Ltd.$4.1B
- Two Sigma Spectrum Cayman Fund, Ltd.$3.0B
- Market Advantage, Ltd.$2.6B
- Two Sigma Risk Premia Enhanced Cayman Fund, Ltd.$2.5B
- Concordia G-10 Fixed Income Relative Value, Ltd.$2.5B
- Owl Creek Overseas Fund, Ltd.$1.8B